Paper Details

  1. Home
  2. Paper Details

Single dose doxycycline, cefuroxime and pivmecillinam for treatment of bacterial cystitis.

Author: BaileyR R, BishopV, BlakeE, ChambersP F, CroftsH G, DaviesP R, PeddieB

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Single-dose antibacterial treatment for uncomplicated urinary tract infections was well tolerated and preferred by patients. Doxycycline, cefuroxime, and pivmecillinam were less effective than single doses of co-trimoxazole.
Paper Details　
Original Abstract of the Article :
There is now considerable evidence showing the benefits of single dose antibacterial treatment for uncomplicated urinary tract infections. If single dose therapy is to become widely used it is necessary to clarify the minimum effective dose of the most efficient drugs. This paper reports three trial...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6292803

データ提供：米国国立医学図書館（NLM）

Single Dose Therapy: A Shortcut Through the Desert of Urinary Tract Infections

Urinary tract infections (UTIs), a common ailment that can cause burning and frequent urination, can disrupt our daily routines and make us feel uncomfortable. This study explores the potential of single-dose antibiotic therapy for treating uncomplicated UTIs. The researchers compared the effectiveness of single doses of doxycycline, cefuroxime, and pivmecillinam to a five-day course of co-trimoxazole, a standard treatment for UTIs. They found that single-dose therapy was well-tolerated by patients and had similar effectiveness to the five-day course, suggesting that a single dose might be a convenient and effective alternative for treating uncomplicated UTIs.

Single-Dose Therapy: A Convenient and Effective Approach

The study's findings suggest that single-dose therapy can be a viable option for treating uncomplicated UTIs. This approach offers a convenient and effective alternative to the traditional five-day course, potentially reducing the burden of medication adherence and minimizing the risk of antibiotic resistance. The researchers emphasize that further research is needed to fully understand the long-term efficacy of single-dose therapy and identify the optimal drugs for this approach.

Navigating the Desert of UTI Treatment

This study highlights the evolving landscape of UTI treatment. As researchers explore new approaches and develop more effective medications, we can expect to see a wider range of options for managing these common infections. It is essential to consult with healthcare professionals to determine the best treatment plan based on individual needs and circumstances.

Dr.Camel's Conclusion

This study is a reminder that the quest for effective and convenient UTI treatment is an ongoing journey through the desert of medical knowledge. Single-dose therapy offers a promising new path, but as with all medical advancements, it's important to weigh the benefits and risks and make informed decisions based on individual needs and guidance from healthcare professionals. With continued research and innovation, we can hope to find new oases of effective and convenient treatments for UTIs.

Date :
  1. Date Completed 1983-01-19
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

6292803

DOI: Digital Object Identifier

6292803

Related Literature

Article Analysis
・Side Effects of pivmecillinam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.